LifeScienceXchange

LifeScienceXchange offers actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format. LifeScienceXchange multiplies the impact of biologics and immunotherapy R&D, bringing new treatments to patients faster.

Editor's Top Picks

Market Insight

Empowering Peptide Science with Open Source Tools

Rodrigo Ochoa Senior Scientist, Novo Nordisk

Market Insight

FORCE: Delivering Oligos to Beat Rare Muscular Diseases

Timothy Weeden Executive Director, Head of Platform Development, Dyne Therapeutics

Market Insight

Cracking the Solid Tumour Code with CAR T Cells

John Maher Chief Scientific Officer, Leucid Bio

Market Insight

Leveraging Neoantigens for Personalised Cancer Vaccines

Daniela Kleine-Kohlbrecher Senior Project Manager, Evaxion

Technology Spotlight

Revolutionizing Antibody Discovery: Machine Learning and Bioinformatics at Work

Kris Modig Field Application Scientist, PipeBio

e-book

Latest Technology Spotlights

Accelerate Your Biologics Design with Computational Modelling Tools

Venturing Beyond Monoclonal Antibodies with GenScript

Boosting Immunotherapy Success with Fun Ways to Bridge Preclinical and Clinical Worlds

NeXT Personal: An Ultra-Sensitive MRD Liquid Biopsy for Early Stage Cancer Recurrence Detection

Latest News

Zymeworks Granted IND Clearance for Novel ADC, ZW251

Multiple Myeloma mRNA Cancer Vaccine Slows Tumour Growth in Mice

Promising Phase I Results from Osteoarthritis Gene Therapy

Thought Leadership

Developing Therapies for Cardiac Failure Using Neonatal Cardiac Progenitor Cells: Interview with Secretome Therapeutics

Rachana Mishra Co-Founder and Senior Director of CMC, Secretome Therapeutics

Sudhish Sharma Co-Founder, Director of Preclinical Research, Secretome Therapeutics

Enabling Strategies for Advanced Therapy Operations: Interview with Radix Partners

Cristian Circiumaru Managing Director, Radix Partners

AI-Enabled Biologics Data Analysis For All: Interview with baSeq

Mikkel Reincke Fuglsang CEO & Co-founder, baSeq

Cell 2025 Banner

Market Insight: Across Modalities

Preclinical Development of STING-Agonist Small Molecule Cancer Therapies

TACAs: Opening up the Target Space to a New Frontier

Challenges and Solutions in the Purification of Oligonucleotides

Protein Corona and Freeze-Thaw Stability in Lipid Nanoparticles

The Allosteric Way: Safer & More Effective Next-Gen Small Molecules

Alphamers: A Novel Immunotherapy Platform

Snakebite Medicines: Venom Derived Peptides for Therapeutic Indications

AI-Powered Peptide Design: Transforming Drug Discovery with Machine Learning

Cell-Free Cancer Vaccines Developed in Two Weeks

Potency Testing in RNA Therapeutics